Loading clinical trials...

Genetics in Predicting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid | Clinical Trials | Clareo Health

Back to clinical trial search

WITHDRAWNNANCT02069340

Genetics in Predicting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid

This randomized clinical trial studies genetics in predicting risk of bisphosphonate-related osteonecrosis of the jaw in patients with cancer receiving zoledronic acid. Zoledronic acid is an anti-reso...

Lead sponsor: University of Southern California•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGNA

Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

NCT04693377 · Castration-Resistant Prostate Carcinoma, Metastatic Colorectal Carcinoma, and more

RECRUITINGPhase 3

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

NCT06500455 · Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, and more

RECRUITING

Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors

NCT07487883 · Non-Small Cell Lung Cancer, Malignant Neoplasm, and more

RECRUITING

Swedish Ibrance Registries Insights (SIRI)

NCT04654208 · Malignant Neoplasm of Breast

RECRUITING

Construction and Evaluation of Tumor Immunotherapy and Organ Damage Early Warning System Based on Multi-omics

NCT07131007 · Malignant Neoplasm, Organ Damage

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 11, 2017Terms

Trial snapshot

StatusWITHDRAWN

PhaseNA

Enrollment—

Start dateJun 2016

Last updatedApr 11, 2017

Condition

Malignant Neoplasm Musculoskeletal Complications

Locations shown

USC Norris Comprehensive Cancer Center

Los Angeles, California

J.Craig Venter Institute-San Diego

San Diego, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 11, 2017Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Genetics in Predicting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors

Swedish Ibrance Registries Insights (SIRI)

Construction and Evaluation of Tumor Immunotherapy and Organ Damage Early Warning System Based on Multi-omics

Trial snapshot

Condition

Locations shown

For caregivers